Post-COVID isolated subclavian artery dissection with multiple cerebral infarctions

Background Coronavirus disease 2019 (COVID-19) is a pandemic disease which predominantly affects the respiratory system with high critical care mortality and morbidity, yet it also causes multiple organs dysfunction in affected patients. There is a strong evidence that it increases the susceptibilit...

Full description

Saved in:
Bibliographic Details
Published inThe Egyptian Journal of Neurology, Psychiatry and Neurosurgery Vol. 58; no. 1; pp. 114 - 5
Main Authors Alloush, Taha K., Alloush, Adel T., Marzouk, Fayez, Abdulghani, Khaled O., Shokri, Hossam M.
Format Journal Article
LanguageEnglish
Published Berlin/Heidelberg Springer Berlin Heidelberg 01.10.2022
Springer Nature B.V
SpringerOpen
Subjects
Online AccessGet full text
ISSN1110-1083
1687-8329
DOI10.1186/s41983-022-00549-8

Cover

More Information
Summary:Background Coronavirus disease 2019 (COVID-19) is a pandemic disease which predominantly affects the respiratory system with high critical care mortality and morbidity, yet it also causes multiple organs dysfunction in affected patients. There is a strong evidence that it increases the susceptibility of cerebrovascular strokes in such patients. Besides this prothrombotic complication, arterial dissection can be one of its mechanisms increasing the risks of stroke. Case presentation Herein, we report a case of spontaneous isolated subclavian artery dissection in a COVID-19 patient. Sixty-one-year-old female presented with spontaneous isolated subclavian artery dissection without any traumatic events nor history of connective tissue disorders. She had left upper limb ischemia followed by cerebellar, thalamic and occipital infarctions. Whether this patient’s subclavian artery dissection was triggered by exaggerated inflammatory response or arteriopathy secondary to COVID-19 remains speculative. Conclusions Nonetheless, arterial dissection can be one of its complications, it is essential for treating physicians to be attentive for the diversity of COVID-19 clinical manifestations.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Case Study-2
ObjectType-Feature-4
content type line 23
ObjectType-Report-1
ObjectType-Article-3
ISSN:1110-1083
1687-8329
DOI:10.1186/s41983-022-00549-8